José Antonio Mesa Cejudo
Director/Board Member at Sagetis Biotech SL
Network origin in José Antonio Mesa Cejudo first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Altamar Private Equity SGIIC SA /Private Equity/
 Altamar Private Equity SGIIC SA /Private Equity/ Investment ManagersFinance Altamar Private Equity SGIIC SA (Altamar Private Equity) is a private equity arm of Altamar Capital Partners SL founded in 2004. The firm is headquartered in Spain with additional offices in New York and Santiago de Chile.
26
| Subsidiary | Investment Managers | 26 |
Caixa Capital Risc SGEIC SA
 Caixa Capital Risc SGEIC SA Investment ManagersFinance Caixa Capital Risc SGEIC SA (Caixa Capital Risc) is a venture capital armof Criteria Caixa SA founded in 2002. The firm is headquartered in Barcelona, Spain with additional offices in Madrid.
26
| Subsidiary | Investment Managers | 26 |
Sanifit Therapeutics SA
 Sanifit Therapeutics SA BiotechnologyHealth Technology Sanifit Therapeutics SA develops pharmaceuticals for calcification disorders. Its pipeline consists of treatments for calcification disorders, such as calciphylaxis and osteoporosis. The company was founded by Felix Grases in 2004 and is headquartered in Palma de Mallorca, Spain.
9
| Subsidiary | Biotechnology | 9 |
Ona Therapeutics SL
 Ona Therapeutics SL Pharmaceuticals: MajorHealth Technology Ona Therapeutics SL is a biotech company based in Barcelona, Spain that specializes in discovering and developing therapeutic biologics targeting tumor metastatic-initiating cells and lipid metabolism. The Spanish company's focus is on developing novel therapies against advanced cancer. The company was founded in 2019 by Salvador Aznar Benitah and Valerie Liesbeth Brigitte Vanhooren, with Valerie Liesbeth Brigitte Vanhooren serving as CEO since incorporation.
9
| Holding Company | Pharmaceuticals: Major | 9 |
Inbiomotion SL
 Inbiomotion SL Medical SpecialtiesHealth Technology Inbiomotion SL designs and develops diagnostic assays. It focus on genetic biomarkers, which predict the bone-specific metastases in cancer patients. The firm develops biomarker in breast cancer primary tumors for predicting the bone relapse. The company was founded by in 2010 and is headquartered in Barcelona, Spain.
8
| Holding Company | Medical Specialties | 8 |
Medlumics SL
 Medlumics SL Medical SpecialtiesHealth Technology Medlumics SL provides medical imaging diagnostics services. It specializes in optically guided medical devices. The firm’s proprietary integrated optics platform technology combines optical and electrical components in a miniature chip, enabling for the first time complex multi view optical probes of the size of a grain of rice and ultra-portable, hand-held OCT systems that produces real-time images. The company was founded by Eduardo Margallo Balbás and Jose Luis Rubio Guivernau on April 3, 2009 and is headquartered in Tres Cantos, Spain.
6
| Holding Company | Medical Specialties | 6 |
Columbus Venture Partners SGEIC SA
 Columbus Venture Partners SGEIC SA Investment ManagersFinance Columbus Venture Partners SGEIC SA (Columbus VP) is an independent Spanish venture capital firm which was founded in 2015 by Javier García Cogorro and Damià Tormo Carulla. The firm headquartered in Madri, Spain.
6
| Private Company | Investment Managers | 6 |
Accure Therapeutics SL
 Accure Therapeutics SL Pharmaceuticals: MajorHealth Technology Accure Therapeutics SL is an R & D pharma Spanish company that focuses on developing innovative medicines to treat patients suffering from central nervous system diseases. Accure Therapeutics is based in Barcelona, ES, and has subsidiaries in Spain. The company's research is centered on neurons that suffer dysfunction and the glial environment that supports them, with the aim of impeding their degeneration and death. The company was founded in 2020 by Laurent Nguyen, who has been the CEO since then.
5
| Holding Company | Pharmaceuticals: Major | 5 |
MTrap, Inc.
 MTrap, Inc. Miscellaneous Commercial ServicesCommercial Services MTrap, Inc. engages in the development of novel therapeutic devices that interfere with the intense dialogue and crosstalk between the primary tumor and the microenvironment and represent a new disruptive approach to cancer treatment. The company was founded by Maybelle L. Jordan and is headquartered in Huntington, NY.
4
| Holding Company | Miscellaneous Commercial Services | 4 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.
4
| Subsidiary | Medical Specialties | 4 |
DeepUll Diagnostics SL
 DeepUll Diagnostics SL Engineering & ConstructionIndustrial Services DeepUll Diagnostics SL provides technical engineering and consulting services. The company is based in Barcelona, Spain. The Spanish company was founded in 2019 by Jordi Carrera Fabra and Rafel Bru. Jordi Carrera Fabra has been the CEO since 2019.
3
| Holding Company | Engineering & Construction | 3 |
Minoryx Therapeutics SL
 Minoryx Therapeutics SL BiotechnologyHealth Technology Minoryx Therapeutics SL engages in the development of drugs for the orphan genetic diseases of the central nervous system. The company was founded by Marc Martinell, Joan Aymami, Nigel Ten Fleming and Xavier Barril in 2011 and is headquartered in Barcelona, Spain.
3
| Holding Company | Biotechnology | 3 |
Sagetis Biotech SL
 Sagetis Biotech SL BiotechnologyHealth Technology Sagetis Biotech SL designs and develops drug-delivery technologies. Its polymeric-based platforms are designed to address areas such as" delivery through the blood-brain barrier, genetic material transfection, and tissue regeneration. The company was founded by David Horna, Eduard Diviu Terradas and Salvador Borros Gomez on April 14, 2010, and is headquartered in Barcelona, Spain.
2
| Holding Company | Biotechnology | 2 |
Aelix Therapeutics SL
 Aelix Therapeutics SL BiotechnologyHealth Technology Aelix Therapeutics SL researches and develops therapies for HIV. It develops therapeutic vaccines and immunotherapies to treat HIV infection. The firm is a spin-off of HIVACAT, the Catalan project for the development of effective vaccines against HIV. The company was founded by Christian Brander, Bonaventura Clotet, Josep Maria Gatell and Jordi Naval is headquartered in Barcelona, Spain.
1
| Holding Company | Biotechnology | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to José Antonio Mesa Cejudo via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
Conventus Orthopaedics, Inc.
 Conventus Orthopaedics, Inc. Hospital/Nursing ManagementHealth Services Conventus Orthopaedics, Inc. operates as a medical device company for fracture treatment. It focuses on creating less invasive solutions for fractures in and around the joints. The firm offers distal radial and wrist fracture repair products. Its products include distal radius and proximal humerus. The company was founded by Michael P. Brenzel and Paul J. Hindrichs in 2009 and is headquartered in Maple Grove, MN. | Hospital/Nursing Management | Director/Board Member Director/Board Member | |
| AURA BIOSCIENCES, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| ATRECA, INC. | Biotechnology | Director/Board Member | |
Artax Biopharma, Inc.
 Artax Biopharma, Inc. Medical SpecialtiesHealth Technology Artax Biopharma, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the development of new therapies for autoimmune and inflammatory diseases. The firm develops drugs targeting the interaction between T-cell Receptors (TCR) and Nck, a cytoplasmic adapter protein which plays a role in T-cell activation. The company was founded by Dami? Carulla Tormo in 2013 and is headquartered in Cambridge, MA. | Medical Specialties | Chief Executive Officer Director/Board Member Founder | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Graduate Degree | |
European Investment Fund
 European Investment Fund Investment ManagersFinance European Investment Fund (EIF) is a venture capital firm founded in 1994. The firm is headquartered in Luxembourg. | Investment Managers | Private Equity Investor Private Equity Investor | |
| Universität zu Köln | College/University | Undergraduate Degree Undergraduate Degree | |
| Universidad Complutense de Madrid | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| University of Barcelona | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
| Swiss Federal Institute of Technology | College/University | Doctorate Degree Doctorate Degree | |
| Universidad de Buenos Aires | College/University | Graduate Degree Doctorate Degree | |
Ogeda SA
 Ogeda SA Pharmaceuticals: MajorHealth Technology Ogeda SA discovers and develops small molecule drugs. It develops NK3 antagonists for the treatment of hormone-dependent pathologies in the field of Women's Health. The company was founded in 1994 and is headquartered in Gosselies, Spain. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Universitat Pompeu Fabra | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree | |
| Escuela Superior de Administración y Dirección de Empresas | College/University | Masters Business Admin Graduate Degree Masters Business Admin Graduate Degree | |
Riva y García Gestión SGIIC SA /New/
 Riva y García Gestión SGIIC SA /New/ Investment ManagersFinance Riva y García Gestión SGIIC SA (Riva y Garcia Private Equity) is a private equity and venture capital subsidiary of Grupo Financiero Riva y García SL /New/ founded in 2000 by Borja García-Nieto Portabella. It is headquartered in Barcelona, Spain. | Investment Managers | Private Equity Investor Private Equity Analyst | |
| Ramon Llull University | College/University | Graduate Degree Graduate Degree | |
Meridia Capital Partners SGEIC SA
 Meridia Capital Partners SGEIC SA Investment ManagersFinance Meridia Capital Partners SGEIC SA is an Independent Private Equity firm founded in 2006 by Javier Faus Santasusana. The firm is headquartered in Barcelona. | Investment Managers | Private Equity Investor Private Equity Investor | |
| CAIXABANK, S.A. | Regional Banks | Chairman Corporate Officer/Principal | |
| Instituto Catolico de Administracion y Direccion de Empresas | College/University | Masters Business Admin Undergraduate Degree | |
Ysios Capital Partners SGEIC SA
 Ysios Capital Partners SGEIC SA Investment ManagersFinance Ysios Capital Partners SGEIC SA (Ysios Capital) is a venture capital firm founded in 2007 by Joël Jean Pierre Jean-Mairet, Julia Salaverría Monfort and Josep Lluís Sanfeliu Benet. The firm is headquartered in San Sabastian, Spain with additional office in Barcelona. | Investment Managers | Founder Private Equity Investor Private Equity Investor | |
| REGULUS THERAPEUTICS INC. | Pharmaceuticals: Major | Director of Finance/CFO President Chief Tech/Sci/R&D Officer | |
Palau Pharma SA
 Palau Pharma SA BiotechnologyHealth Technology Palau Pharma SA is a holding company engaged in the discovery and development of biophamaceuticals for the treatment of inflammatory and autoimmune diseases, such as rheumatoid arthritis, neuropathic pain, and chronic obstructive pulmonary disease. The company was founded on March 13, 1991 and is headquartered in Palau Solita i Plegamans, Spain. | Biotechnology | Director of Finance/CFO Corporate Officer/Principal | |
| University Carlos III of Madrid | College/University | Undergraduate Degree Undergraduate Degree | |
| ARGENX SE | Pharmaceuticals: Other | Director/Board Member Director/Board Member | |
Ape Software Components SL
 Ape Software Components SL Packaged SoftwareTechnology Services Ape Software Components SL engages in the development and provision of business intelligence software platforms. The firm provides data cycle reporting, data cycle my vision, apesoft knowledge center and pricing and bundles products. It offers solutions for performance monitoring, financial reporting; excel automation and integration, and data center management. The company was founded by Jaume Juan Castillo in 1994 and is headquartered in Cerdanyola del Valles, Spain. | Packaged Software | Director/Board Member Director/Board Member | |
Groupalia Compra Colectiva SL
 Groupalia Compra Colectiva SL Catalog/Specialty DistributionRetail Trade Groupalia Compra Colectiva SL owns and operates an online discount voucher portal. It hosts coupons and offers for local and international travel, health and wellness, educational courses, and restaurants, as well as home decor and consumer electronics. The company was founded by Joaquin Engel on March 8, 2010 and is headquartered in Barcelona, Spain. | Catalog/Specialty Distribution | Director/Board Member Director/Board Member | |
iTeos Therapeutics SA
 iTeos Therapeutics SA Pharmaceuticals: MajorHealth Technology iTeos Therapeutics SA engages in the discovery of immunomodulators for cancer therapy. It operates as a biotechnology company which focuses on targeting metabolism of the tumor microenvironment through development of small-molecule immunomodulators for cancer treatment. The firm develops small molecules designed to target the tumor microenvironment by inhibiting cancer-induced immune suppression. Targeting such resistance mechanisms will enhance the clinical efficacy of both standards of care treatments as well as the newer immunomodulatory therapies based on the blockade of immune checkpoints. The company was founded in 2011 by Michel Detheux and Benoit Van den Eynde and is headquartered in Gosselies, Belgium. | Pharmaceuticals: Major | Director/Board Member Founder | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
Rainier Therapeutics, Inc.
 Rainier Therapeutics, Inc. BiotechnologyHealth Technology Rainier Therapeutics, Inc. operates as a biotechnology company that develops a targeted biologic for the potential treatment of metastatic bladder cancer. It provides Vofatamab, an antibody that is focused on the fibroblast growth factor of bladder and other cancer. The company was founded by Stephen Lau and is headquartered in San Leandro, CA. | Biotechnology | Director/Board Member Director/Board Member | |
Axon Therapies, Inc.
 Axon Therapies, Inc. BiotechnologyHealth Technology Axon Therapies, Inc. develops treatment for heart failure. The company is headquartered in New York, NY. | Biotechnology | Director/Board Member Director/Board Member | |
Deerfield Management Co. LP (Private Equity)
 Deerfield Management Co. LP (Private Equity) Investment ManagersFinance Deerfield Management Co. LP (Private Equity) (Deerfield) is a private equity subsidiary of Deerfield Management Co. LP founded in 1994. The firm is headquartered in the New York. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
Fund+
 Fund+ Investment ManagersFinance Fund+ is an independent Venture Capital firm founded in 2015. The firm is headquartered in Leuven, Belgium. | Investment Managers | Private Equity Investor Private Equity Investor | |
Psico Smart Apps SL
 Psico Smart Apps SL Packaged SoftwareTechnology Services Psico Smart Apps SL develops a cloud-based mobile application for treating phobias for therapists. The company offers virtual reality (VR) kit, Psious platform and biofeedback. It offers Psious platform offers the benefits of virtual reality quickly and easily, through smartphone and 3D goggles, with no need for costly or complex equipment investments. The company was founded by Xavier Palomer Ripoll and Daniel Roig Canelles and is headquartered in Barcelona, Spain. | Packaged Software | Director/Board Member Chief Operating Officer | |
| UNITY BIOTECHNOLOGY, INC. | Biotechnology | Director/Board Member | |
eTheRNA immunotherapies NV
 eTheRNA immunotherapies NV BiotechnologyHealth Technology eTheRNA immunotherapies NV develops novel immunotherapies to overcome cancers and infectious diseases. The company was founded by Carlo Heirman, Kris Thielemans and Sonja van Meirvenne in January 21, 2013 and is headquartered in Niel, Belgium. | Biotechnology | Director/Board Member Director/Board Member | |
4Founders Capital SGEIC SA
 4Founders Capital SGEIC SA Investment ManagersFinance 4founders Capital SGEIC SA (4Founders Capital) is a venture capital firm founded in 2016. It is headquartered in Barcelona, Spain. | Investment Managers | Founder Private Equity Investor | |
Highlight Therapeutics SL
 Highlight Therapeutics SL Pharmaceuticals: MajorHealth Technology Highlight Therapeutics develops ribonucleic acid-based therapies and novel targets in cancer and immune cells. Its product BO-112, induces immunogenic cell death in solid tumors and simultaneously activates the innate immune system to ensure optimal antigen processing and presentation to the adaptive immune system. The company was founded by Damia tormo Carulla and is headquartered in Paterna, Spain. | Pharmaceuticals: Major | Director/Board Member Founder | |
GlyCardial Diagnostics SL
 GlyCardial Diagnostics SL Miscellaneous Commercial ServicesCommercial Services GlyCardial Diagnostics SL has developed a biomarker called iSCOR that can detect cardiac ischemia through a blood test. The company is based in Barcelona, Spain. Early detection of ischemia can prevent myocardial damage. The Spanish company was founded in 2017 by Rafols Judit Cubedo, Lina Badimon Maestro, Capmany Teresa Padro, and Gemma Vilahur. Rafols Judit Cubedo has been the CEO since 2017. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
SpliceBio SL
 SpliceBio SL BiotechnologyHealth Technology SpliceBio SL is a genetic medicines company based in Barcelona, Spain. The Spanish company harnesses its proprietary protein splicing platform to develop the next generation of gene therapies. SpliceBio's platform offers the potential to address diseases that currently cannot be treated with gene therapies because the necessary gene is too large to be delivered by -associated virus (AAV) vectors. The company's lead program targets Stargardt disease, a genetic eye disease that causes vision loss in children and adults. SpliceBio's platform is based on technology developed in the Muir lab at Princeton University after more than 20 years of pioneering intein and protein engineering research. The company was founded by Dominguez Silvia Frutos, Miquel Vila-Perelló, and Miquel Vila-Perelló has been the CEO since incorporation. | Biotechnology | Director/Board Member Director/Board Member | |
Asabys Partners SGEIC SA
 Asabys Partners SGEIC SA Investment ManagersFinance Asabys Partners SGEIC SA (Asabys Partners) is an independent venture capital firm founded in 2019 by Clara Campàs-Moya and Josep Lluís Sanfeliu Benet. The firm is headquartered in Barcelona, Spain. | Investment Managers | Private Equity Investor Private Equity Analyst | |
| Altamar Partners North America LLC | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
Frontier Medicines Corp.
 Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Frontier Medicines Corp. develops medicines that redefine the course of debilitating diseases. The company was founded by Chris Varma, Daniel K. Nomura and Roberto Zoncu in 2018 and is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Altamar Cam Partners SL
 Altamar Cam Partners SL Financial ConglomeratesFinance Altamar CAM Partners SL is an independent, partner-led, private asset manager and solutions provider with over €17.5b in assets under management. The private company is based in Madrid, ES. The Spanish company provides solutions for private markets and its annual report for 2022 highlights its growth and excellent performance. and has a global presence of subsidiaries in several regions. The company was founded in 2004. José Luis Molina Domínguez has been the CEO of the company since 2004. | Financial Conglomerates | Director/Board Member Private Equity Analyst | |
| Universidad Pontificia Comillas | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree |
Statistics
International
| Spain | 24 |
| United States | 18 |
| Belgium | 5 |
| Germany | 3 |
| Greece | 2 |
Sectoral
| Health Technology | 22 |
| Consumer Services | 14 |
| Finance | 12 |
| Technology Services | 3 |
| Health Services | 2 |
Operational
| Director/Board Member | 294 |
| Private Equity Investor | 79 |
| Corporate Officer/Principal | 73 |
| Chairman | 55 |
| Undergraduate Degree | 55 |
Most connected contacts
| Insiders | |
|---|---|
| Isidro Fainé Casas | 52 |
| Steve Hochberg | 47 |
| Andrew ElBardissi | 32 |
| Thomas O. Hecht | 24 |
| Wolfgang Reim | 24 |
| Cameron Wheeler | 20 |
| Stephen Aselage | 20 |
| Pamela Klein | 19 |
| Casper Breum | 18 |
| Joël Jean-Mairet | 17 |
| Preston Klassen | 15 |
| Alexandra Tolia | 15 |
| Joseph Lobacki | 15 |
| Pablo Cironi | 14 |
| Jordi Iserte | 12 |
- Stock Market
- Insiders
- José Antonio Mesa Cejudo
- Company connections
